NCT01559857View on ClinicalTrials.gov

Pioglitazone in Patients With Mood Disorders

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

June 30, 2014

Conditions
Major Depressive DisorderInsulin Resistance
Interventions
DRUG

Pioglitazone

30mg once daily for 12 weeks

DRUG

Sugar Pill

Placebo

Trial Locations (1)

94305

Stanford University Department of Psychiatry & Behavioral Sciences, Palo Alto

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Stanford University

OTHER

NCT01559857 - Pioglitazone in Patients With Mood Disorders | Biotech Hunter | Biotech Hunter